Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Biochemical Pharmacology|February 15, 1986
Enzymatic defense against radiation damage in mice. Effect of selenium and vitamin E depletionG Batist, A Reynaud, A G Katki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group studyC Cripps, M Burnell, J Jolivet, et al.
Cancer Research|August 1, 1986
Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopyJ S Cohen, R C Lyon, C Chen, et al.
Journal of Bacteriology|October 1, 1974
Promoter-like mutation affecting HPr and enzyme I of the phosphoenolpyruvate: sugar phosphotransferase system in Salmonella typhimuriumJ C Cordaro, R P Anderson, E W Grogan, et al.
Current Oncology (Toronto, Ont.)|November 2, 2017
Lung cancer care trajectory at a Canadian centre: an evaluation of how wait times affect clinical outcomesG Kasymjanova, D Small, V Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Phase II study of troxacitabine in chemotherapy-naive patients with advanced cancer of the pancreas: gastrointestinal tumorsR Lapointe, R Létourneau, W Steward, et al.
International Journal of Cancer|September 27, 1996
Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitisG M Kirby, G Batist, N Fotouhi-Ardakani, et al.
Cancer Research|July 1, 1985
A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880)G A Curt, J A Kelley, R L Fine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancerL C Alpert, R L Schecter, D A Berry, et al.
Oncogene|August 3, 2000
Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesisL Yen, X L You, A E Al Moustafa, et al.
Pageof 12